Literature DB >> 15086667

Out-of-pocket healthcare expenditures of older Americans with depression.

Jeffrey S Harman1, Kelly J Kelleher, Charles F Reynolds, Harold Alan Pincus.   

Abstract

The objective of this study was to estimate mean annual out-of-pocket (OOP) healthcare expenditures of Americans aged 65 and older with self-reported depression and compare these expenditures with the OOP expenditures of older Americans with hypertension, heart disease, diabetes mellitus, and arthritis. Data from the 1999 Medical Expenditure Panel Survey, which employs a nationally representative stratified random sample of households in the United States, were used to estimate mean OOP expenditures for health care during 1999. The data were limited to observations on individuals aged 65 and older living in households in the United States included in the 1999 Medical Expenditure Panel Survey sample (N=2,730). Mean OOP expenditures for older Americans with depression were $1,835 in 1999. Most of the spending ($1,090) was for prescription drugs in this population. For patients with depression, only 8% of total OOP spending was for depression-specific services and treatments. Mean OOP spending was greater for persons with depression than it was for older Americans with hypertension ($1,181) and arthritis ($1,190), whereas OOP spending for depression was similar to spending of older Americans with heart disease ($1,412) and diabetes mellitus ($1,527). Older Americans with depression have high OOP expenditures, with most of this spending for health services and drugs to treat general medical conditions.

Entities:  

Mesh:

Year:  2004        PMID: 15086667     DOI: 10.1111/j.1532-5415.2004.52224.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

1.  Differences in medical care expenditures for adults with depression compared to adults with major chronic conditions.

Authors:  Ithai Z Lurie; Larry M Manheim; Dorothy D Dunlop
Journal:  J Ment Health Policy Econ       Date:  2009-06

2.  Do HIV-positive women receive depression treatment that meets best practice guidelines?

Authors:  Judith A Cook; Jane K Burke-Miller; Dennis D Grey; Jennifer Cocohoba; Chenlong Liu; Rebecca M Schwartz; Elizabeth T Golub; Kathryn Anastos; Pamela J Steigman; Mardge H Cohen
Journal:  AIDS Behav       Date:  2014-06

3.  Does medication adherence following a copayment increase differ by disease burden?

Authors:  Virginia Wang; Chuan-Fen Liu; Christopher L Bryson; Nancy D Sharp; Matthew L Maciejewski
Journal:  Health Serv Res       Date:  2011-06-20       Impact factor: 3.402

4.  Effects of depression on the subsequent year's healthcare expenditures among older adults: two-year panel study.

Authors:  Sunha Choi; Leslie Hasche; Duy Nguyen
Journal:  Psychiatr Q       Date:  2015-06

5.  Primary care physician office visits for depression by older Americans.

Authors:  Jeffrey S Harman; Peter J Veazie; Jeffrey M Lyness
Journal:  J Gen Intern Med       Date:  2006-09       Impact factor: 5.128

6.  Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study.

Authors:  Sandipan Bhattacharjee; Majed Al Yami; Sawsan Kurdi; David Rhys Axon
Journal:  BMC Psychiatry       Date:  2018-05-16       Impact factor: 3.630

7.  Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States.

Authors:  Omar A Almohammed; Abdulaziz A Alsalem; Abdullah A Almangour; Lama H Alotaibi; Majed S Al Yami; Leanne Lai
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.240

8.  Economic burden to primary informal caregivers of hospitalized older adults in Mexico: a cohort study.

Authors:  Mariana López-Ortega; Carmen García-Peña; Víctor Granados-García; José Juan García-González; Mario Ulises Pérez-Zepeda
Journal:  BMC Health Serv Res       Date:  2013-02-08       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.